Hair Growth Treatment
Today, we begin a series of articles on new companies entering the hair growth industry. One of these companies, Eirion Therapeutics, has treatments for androgenic alopecia as well as hair graying in their pipeline. Topadur Pharma M119 Based in Switzerland, Topadur Pharma is a clinical stage pharmaceutical company with a focus on the cGMP (cyclic…
Read More
Update: Histogen Ends HST-001 (6/3/21) Histogen has announced that it is suspending the development of HST-001 aka HSC. Their latest press release appears to mark the end of the 12 year run that the “hair stimulating complex” had in this industry. Although the diplomatic word “suspending” was used, we can be all but sure this…
Read More
Today, the laboratory of Dr. Tsuji at the Riken Institute has published a new research paper identifying key cells for the purpose of hair regeneration. It appears this knowledge will be useful in creating a functional hair cloning therapy. Hair Follicle Epithelial Stem Cells The new study by Tsuji et al. titled “Expansion and characterization…
Read More
In this article we will take a look at the pipeline of Carthronix, a new biotech company developing therapeutics for stem cell activation and tissue regeneration. CarthroniX is based in Lancaster, CA, a city in northern Los Angeles County. The company was founded by Dr. Denis Evseenko MD, PhD, and Dr. Ben Van Handel and…
Read MoreTH16 Release Update (2/25/21) As mentioned, the all-natural OTC hair growth product TH16 by Triple Hair was slated to be released in Q1 2021. Not very unsurprisingly, it seems that the projected timeframe will have a slight delay. Today, I heard back from Attila Hajdu, Triple Hair VP of Business Development, who was able to…
Read More
Follica announced today the completion of a female pilot study utilizing its proprietary microneedling device along with topical drug application. Female Hair Growth Study On December 8, 2020, a peer-reviewed study sponsored by Follica and titled “A Pilot Evaluation of Scalp Skin Wounding to Promote Hair Growth in Female Pattern Hair Loss” was published in…
Read More
Moogene Medi of South Korea is the first company to formally introduce a CRISPR-based gene editing hair loss therapy to the world. Description Of CRISPR Therapy For AGA Moogene has developed a microbubble-nanoliposomal delivery system to get gene editing particles directly into the dermal papilla cells of the hair follicle. First, a sequence of sgRNA…
Read More
SULT1A1 + Minoxidil Human Study Published (Update 6/18/21) As foretold by Dr. Andy Goren below, Applied Biology has published a peer-reviewed study comparing the effect of the SULT1A1 booster in conjunction with minoxidil to minoxidil alone. The study titled “SULT1A1 (Minoxidil Sulfotransferase) Enzyme Booster Significantly Improves Response to Topical Minoxidil for Hair Regrowth” was published online…
Read More
Could AI, the hottest topic in science and technology, bring about the new and successful hair growth treatments we have been waiting for? We may find out sooner than you think. Last month, while reading an interesting article on the evolution of drug discovery, I was pleasantly surprised to learn about new research being done…
Read More
In this article I have a brief update to share regarding the anticipated release of a product based on the WAY-316606 research by Giuliani Pharma. After a long break in communication I’ve received some updated information regarding the development of a WAY-316606 analog product from Dr. Barbara Marzani, Project Manager of Research & Development at…
Read More